Prime Medicine
Stock Forecast, Prediction & Price Target
Prime Medicine Financial Estimates
Prime Medicine Revenue Estimates
Prime Medicine EBITDA Estimates
Prime Medicine Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $5.21M 0% | $0 -100% | Avg: $3.65M Low: $147.96K High: $7.15M avg. 0% | Avg: $7.28M Low: $564.60K High: $23.76M avg. 99.38% | Avg: $46.75M Low: $3.62M High: $152.49M avg. 541.82% | Avg: $70.62M Low: $5.47M High: $230.37M avg. 51.06% |
Net Income
% change YoY
| $-165.36M N/A | $-121.82M 26.33% | $-198.13M -62.64% | Avg: $-214.59M Low: $-163.74M High: $-102.79M avg. -8.30% | Avg: $-231.76M Low: $-163.49M High: $-89.14M avg. -8.00% | Avg: $-121.44M Low: $-478.56M High: $24.19M avg. 47.60% | Avg: $-117.80M Low: $-464.22M High: $23.47M avg. 2.99% |
EBITDA
% change YoY
| $-83.51M N/A | $-108.41M -29.81% | $-193.75M -78.71% | Avg: $730.64K Low: $29.59K High: $1.43M avg. 100.37% | Avg: $1.45M Low: $112.92K High: $4.75M avg. 99.38% | Avg: $9.34M Low: $724.74K High: $30.49M avg. 541.82% | Avg: $14.12M Low: $1.09M High: $46.07M avg. 51.06% |
EPS
% change YoY
| -$1.73 N/A | -$1.25 27.74% | -$2.18 -74.4% | Avg: -$1.51 Low: -$1.8 High: -$1.13 avg. 30.78% | Avg: -$1.49 Low: -$1.8 High: -$0.98 avg. 1.14% | Avg: -$1.34 Low: -$5.26 High: $0.27 avg. 10.49% | Avg: -$1.3 Low: -$5.1 High: $0.26 avg. 2.99% |
Operating Expenses
% change YoY
| $84.47M N/A | $116.54M 37.96% | $186.63M 60.14% | Avg: $6.81M Low: $276.11K High: $13.35M avg. -96.34% | Avg: $13.59M Low: $1.05M High: $44.33M avg. 99.38% | Avg: $87.23M Low: $6.76M High: $284.57M avg. 541.82% | Avg: $131.79M Low: $10.21M High: $429.90M avg. 51.06% |
FAQ
What is Prime Medicine stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 8.57% in 2025-2028.
We have gathered data from 10 analysts. Their low estimate is -163.74M, average is -214.59M and high is -102.79M.
What is Prime Medicine stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 173.06% in 2025-2028.
We have gathered data from 8 analysts. Their low revenue estimate is $147.96K, average is $3.65M and high is $7.15M.
What is Prime Medicine stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 11.35% in 2025-2028.
We have gathered data from 10 analysts. Their low earnings per share estimate is -$1.8, average is -$1.51 and high is $-1.13.
What is the best performing analyst?
In the last twelve months analysts have been covering Prime Medicine stock. The most successful analyst is Maury Raycroft.